Ed Casabar

718 total citations
20 papers, 584 citations indexed

About

Ed Casabar is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology and Pharmacology. According to data from OpenAlex, Ed Casabar has authored 20 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 8 papers in Applied Microbiology and Biotechnology and 6 papers in Pharmacology. Recurrent topics in Ed Casabar's work include Antibiotic Use and Resistance (8 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Ed Casabar is often cited by papers focused on Antibiotic Use and Resistance (8 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Ed Casabar collaborates with scholars based in United States, United Kingdom and Japan. Ed Casabar's co-authors include David J. Ritchie, Peggy S. McKinnon, Richard M. Reichley, James L. Gray, Gerald Medoff, W. Claiborne Dunagan, Marc D. Smith, Robert S. Woodward, Elizabeth Neuner and Thomas C. Bailey and has published in prestigious journals such as Clinical Infectious Diseases, The American Journal of Medicine and Transplantation.

In The Last Decade

Ed Casabar

20 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ed Casabar United States 13 241 187 162 150 135 20 584
M. Cecilia Di Pentima United States 14 231 1.0× 239 1.3× 138 0.9× 137 0.9× 108 0.8× 33 641
David X. Li United States 6 217 0.9× 227 1.2× 100 0.6× 79 0.5× 139 1.0× 9 598
Kathryn Dzintars United States 11 320 1.3× 382 2.0× 184 1.1× 187 1.2× 160 1.2× 31 862
Bojana Beovič Slovenia 13 234 1.0× 317 1.7× 166 1.0× 67 0.4× 65 0.5× 46 709
Shannon Chan United States 11 190 0.8× 359 1.9× 118 0.7× 140 0.9× 132 1.0× 19 553
S. Diamantis France 15 208 0.9× 160 0.9× 181 1.1× 101 0.7× 50 0.4× 73 596
Vera Luther United States 11 213 0.9× 239 1.3× 204 1.3× 65 0.4× 108 0.8× 42 567
Joshua Courter United States 17 328 1.4× 234 1.3× 110 0.7× 268 1.8× 101 0.7× 57 778
Hisham Ziglam United Kingdom 13 177 0.7× 114 0.6× 159 1.0× 76 0.5× 63 0.5× 32 538
Gail S. Itokazu United States 10 171 0.7× 210 1.1× 82 0.5× 182 1.2× 91 0.7× 17 561

Countries citing papers authored by Ed Casabar

Since Specialization
Citations

This map shows the geographic impact of Ed Casabar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ed Casabar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ed Casabar more than expected).

Fields of papers citing papers by Ed Casabar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ed Casabar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ed Casabar. The network helps show where Ed Casabar may publish in the future.

Co-authorship network of co-authors of Ed Casabar

This figure shows the co-authorship network connecting the top 25 collaborators of Ed Casabar. A scholar is included among the top collaborators of Ed Casabar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ed Casabar. Ed Casabar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Munigala, Satish, et al.. (2021). Post-exposure prophylaxis for human immunodeficiency virus after sexual assault in a Midwestern U.S. emergency department. The American Journal of Emergency Medicine. 49. 117–123. 4 indexed citations
2.
Tokuda, Yasuharu, et al.. (2019). Methods of estimating vancomycin use in an inpatient setting: days of therapy versus therapeutic drug monitoring–based exposure days. Infection Control and Hospital Epidemiology. 40(3). 375–379. 1 indexed citations
3.
Hsueh, Kevin, Thomas C. Bailey, Ayesha Iqbal, et al.. (2018). A Cluster of Cefepime-induced Neutropenia During Outpatient Parenteral Antimicrobial Therapy. Clinical Infectious Diseases. 69(3). 534–537. 8 indexed citations
4.
Britt, Nicholas, David J. Ritchie, Jeffrey Topal, et al.. (2017). Telavancin for refractory MRSA bacteraemia in intermittent haemodialysis recipients. Journal of Antimicrobial Chemotherapy. 73(3). 764–767. 9 indexed citations
5.
Hsueh, Kevin, Ed Casabar, David J. Ritchie, et al.. (2016). Effective Antibiotic Conservation by Emergency Antimicrobial Stewardship During a Drug Shortage. Infection Control and Hospital Epidemiology. 38(3). 356–359. 12 indexed citations
6.
Marcos, Luis A., Bernard Camins, David J. Ritchie, Ed Casabar, & David K. Warren. (2012). Acute renal insufficiency during telavancin therapy in clinical practice--authors' response. Journal of Antimicrobial Chemotherapy. 67(5). 1301–1302. 1 indexed citations
7.
Wang, Eric W., et al.. (2011). Leech-Transmitted Ciprofloxacin-Resistant Aeromonas hydrophila. Archives of Otolaryngology - Head and Neck Surgery. 137(2). 190–190. 22 indexed citations
8.
Marcos, Luis A., Bernard Camins, David J. Ritchie, Ed Casabar, & David K. Warren. (2011). Acute renal insufficiency during telavancin therapy in clinical practice. Journal of Antimicrobial Chemotherapy. 67(3). 723–726. 18 indexed citations
9.
Spinner, Michael, Georges Saab, Ed Casabar, et al.. (2010). Impact of Prophylactic Versus Preemptive Valganciclovir on Long-Term Renal Allograft Outcomes. Transplantation. 90(4). 412–418. 45 indexed citations
10.
Hladnik, Lindsay, Kristan Augustin, Ed Casabar, et al.. (2010). Use of Cytomegalovirus Intravenous Immune Globulin for the Adjunctive Treatment of Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 30(6). 554–561. 44 indexed citations
11.
Neuner, Elizabeth, Ed Casabar, Richard M. Reichley, & Peggy S. McKinnon. (2010). Clinical, microbiologic, and genetic determinants of persistent methicillin-resistant Staphylococcus aureus bacteremia. Diagnostic Microbiology and Infectious Disease. 67(3). 228–233. 56 indexed citations
12.
Arnold, Heather, Peggy S. McKinnon, Kristan Augustin, et al.. (2009). Assessment of an Alternative Meropenem Dosing Strategy Compared with Imipenem‐Cilastatin or Traditional Meropenem Dosing After Cefepime Failure or Intolerance in Adults with Neutropenic Fever. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 29(8). 914–923. 9 indexed citations
13.
Casabar, Ed, et al.. (2007). Early Clinical Experience with Anidulafungin at a Large Tertiary Care Medical Center. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(1). 64–73. 38 indexed citations
14.
Tantisiriwat, Woraphot, Pablo Tebas, Louis B. Polish, et al.. (2001). Elevated Lactate Levels in Hospitalized Persons with HIV Infection. AIDS Research and Human Retroviruses. 17(3). 195–201. 16 indexed citations
15.
Bailey, Thomas C., et al.. (1997). A randomized, prospective evaluation of an interventional program to discontinue intravenous antibiotics at two tertiary care teaching institutions.. PubMed. 17(2). 277–81. 58 indexed citations
16.
Bailey, Thomas C., David J. Ritchie, S. Troy McMullin, et al.. (1997). A Randomized, Prospective Evaluation of an Interventional Program to Discontinue Intravenous Antibiotics at Two Tertiary Care Teaching Institutions. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 17(2). 277–281. 50 indexed citations
17.
Dunagan, W. Claiborne, Robert S. Woodward, Gerald Medoff, et al.. (1991). Antibiotic Misuse in Two Clinical Situations: Positive Blood Culture and Administration of Aminoglycosides. Clinical Infectious Diseases. 13(3). 405–412. 52 indexed citations
18.
Dunagan, W. Claiborne, Robert S. Woodward, Gerald Medoff, et al.. (1989). Antimicrobial misuse in patients with positive blood cultures☆. The American Journal of Medicine. 87. 253–259. 5 indexed citations
19.
Dunagan, W. Claiborne, Robert S. Woodward, Gerald Medoff, et al.. (1989). Antimicrobial misuse in patients with positive blood cultures. The American Journal of Medicine. 87(3). 253–259. 113 indexed citations
20.
Prince, Randall A., Ed Casabar, Colin G. Adair, et al.. (1989). Effect of Quinolone Antimicrobials on Theophylline Pharmacokinetics. The Journal of Clinical Pharmacology. 29(7). 650–654. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026